Fig 1: ROC curves and cut-offs of IL1-F5 (a), PIP (b), CA-VI (c), serotransferrin (d), and albumin (e), between the No EGUS horses and the EGUS clinical horses. The x-axis represents the % of specificity, and the y-axis the % of sensitivity. The cut-off points represent the value with the best pair sensitivity-specificity.
Fig 2: Salivary biomarker concentrations between the different groups of horses: No EGUS (n = 22) and EGUS clinical subdivided into ESGD (n = 9), EGGD (n = 8) and ESGD + EGGD (n = 11). Mean levels of IL1-F5 (a), PIP (b), CA-VI (c), serotransferrin (d), and albumin (e), where the error bars represent the standard deviation (SD). The p-value is indicated when there were statistically significant differences.
Fig 3: Salivary biomarker concentrations between the different groups of horses: No EGUS (n = 22), EGUS non-clinical (n = 28) and EGUS clinical (n = 28). Mean levels of IL1-F5 (a), PIP (b), CA-VI (c), serotransferrin (d), and albumin (e), where the error bars represent the standard deviation (SD). The p-value is indicated in all comparisons, and the effect size (Cohen d) only when there were statistically significant differences.
Fig 4: Salivary biomarker concentrations between the different groups of horses: No EGUS (n = 22) and EGUS non-clinical subdivided into ESGD (n = 6), EGGD (n = 11) and ESGD + EGGD (n = 11). Mean levels of IL1-F5 (a), PIP (b), CA-VI (c), serotransferrin (d), and albumin (e), where the error bars represent the standard deviation (SD). The p-value is indicated when there were statistically significant differences.
Supplier Page from CUSABIO Technology LLC for Human Prolactin Inducible Protein(PIP)ELISA Kit